Lv2
150 积分 2025-08-12 加入
RAS-targeted therapies: is the undruggable drugged?
8个月前
已完结
Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy
8个月前
已完结
FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions
8个月前
已完结
The next tier of EGFR resistance mutations in lung cancer
8个月前
已完结
皖公网安备34019202002308
